Humira (adalimumab) Disease area(s): Immunology Manufacturer(s): AbbVie 2024 Sales (USD): $8.99 billion Why it sold so well: In 2024, Humira remained a significant revenue contributor for AbbVie, despite facing substantial declines due to biosimilar competition following its US loss of exclusivity in January 2023
Users with tendinopathies, partial tears, and degenerative joint conditions lasting months or years often report significant improvements within 4-8 weeks
This origin explains why the peptide shows such powerful tissue-protective and regenerative properties throughout the body
Transcriptional regulation of the mitochondrial citrate and carnitine/acylcarnitine transporters: two genes involved in fatty acid biosynthesis and -oxidation
We source only from licensed compounding pharmacies using FDA-registered suppliers, ensuring every component meets the highest industry standards for safety and quality
For residents in Dothan, Alabama, and those searching for "Retatrutide near you," the path to increased access involves future FDA approval and the completion of essential clinical trials